Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Applications for the HMGN1 Pathway

Posted Apr 21 2013 8:00pm

Description of Invention:
HMGN1 is a protein that binds to nucleosomes, changes chromatin structure and affects transcription, and the expression of this protein changes during differentiation. Mice lacking this protein have increased growth capacity of several skin components, including epidermis, epidermal appendages, and dermis. Conceivably, this change could be related to an alteration of stem cell differentiation or to cell cycling events. The current invention relates to interference with this pathway, which might lead to increased stem cell differentiation and increased hair cycling and growth in humans as well. This invention might be useful to increase hair growth, enhance wound healing for epidermal and dermal wounds, and enhance stem cell populations for tissue regeneration, gene targeting, or gene therapeutic indications.

Inventors:
Michael Bustin (NCI)


Patent Status:
HHS, Reference No. E-208-2002/0



For Licensing Information Please Contact:
Admin. Licensing Spec-Cancer
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Email: mb715y@nih.gov
Phone: 301-496-7057
Fax: 301-402-0220


Ref No: 821

Updated: 04/2013

Post a comment
Write a comment: